2008—2010年我院抗骨质疏松药物用药分析

Application analysis of anti-osteoporosis from 2008 to 2010 in a hospital

目的了解我院抗骨质疏松药的应用情况及应用趋势。方法对我院2008年1月-2010年12月抗骨质疏松药销售金额、用药频度及日均费用等进行回顾性分析。结果我院抗骨质疏松药品的销售每年的销售金额呈上升趋势，2009年和2010年分别增长43．88％和31．51％；中成药销售金额所占构成比例最高，分别是44．61％、38．81％、34．58％；选择性雌激素受体调节剂销售金额增幅较大，2009年和2010年分别增长237．59％和48．3％；钙剂用药频度最高，DDDs排序，2008年排第二，2009和2010年都排在第一位。结论抗骨质疏松药品的应用情况调查及分析对促进抗骨质疏松药的合理应用及临床用药监护具有重要意义。

Objective To investigate the use and its tendency of anti-osteoporosis in our hospital. Methods The anti-osteoporosis used in Guangzhou Red Cross Hospital from January 2008 to December 2010 was analyzed in respect to consumption sum, defined daily dose （DDDs） and daily drug cost （DDC）, etc. Results The annual consumption sum of anti-osteoporosis showed a upward trend in our hospital during 2008-2010, the growth rate is 43.88% in 2009 and 31.51% in 2010. The Chinese patent medicine is the highest in consumption sum, the ratios are 44.61%, 38.81% and 34.58% respectively; the consumption 6f selective estrogen receptor modulators increased rapidly, the growth rate is 237.59% in 2009 and 48.3% in 2010; the calcium preparations topped the list of antiosteoporosis in terms of DDDs. It ranked second in DDDs in 2008 and the first in 2009 and 2010. Conclusion The application of anti-osteoporosis drugs can promote the rational use and clinical monitoring with great significance.